Regular Exercise Could Be Key to Reducing Your Risk of Alcoholic Liver Disease
Alcohol use and alcoholic liver disease are on the rise globally, and researchers at Mass General are looking for new ways to help.
Contact Information
Boston, MAPhone: 617-726-2426
Danvers, MAPhone: 978-882-6709
Dr. Luther is a Faculty member in the Division of Gastroenterology and Hepatology at the Massachusetts General Hospital. Dr. Luther is the Director of Inpatient Gastroenterology. Additionally, he serves as the Director of the MGH Alcohol Liver Center, whose primary mission is to develop novel strategies to prevent the development of alcohol-associated liver disease. In addition to his busy clinical practice, he leads a clinical research program focused on improving the care of patients with GI/liver diseases. He commits a significant portion of his time to teaching medical students, residents, and fellows within the Harvard system.
Clinical Interests:
Treats:
Mass General Gastroenterology
55 Fruit St.
Boston, MA 02114
Phone: 617-726-2426
Mass General Brigham Healthcare Center
102-104 Endicott St.
Danvers, MA 01923
Phone: 978-882-6709
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Teaching new ways to understand dementia, how to communicate and partner with those with dementia and offer support and guidance for caregivers.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.
Alcohol use and alcoholic liver disease are on the rise globally, and researchers at Mass General are looking for new ways to help.
Study of Mass General Brigham Biobank participants links treatment with reduced incidence and progression of disease.
A team led by researchers from Mass General has uncovered key molecular step stones in alcohol-related liver disease that may provide targets for drug therapy development.